As Pg&E (PCG) Market Valuation Declined, Kwmg Raised Holding; Dicerna Pharmaceuticals (DRNA) Stake Raised by Artal Group Sa

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Logo

Kwmg Llc increased its stake in Pg&E Corp (PCG) by 74.97% based on its latest 2018Q4 regulatory filing with the SEC. Kwmg Llc bought 33,897 shares as the company’s stock declined 34.27% while stock markets rallied. The institutional investor held 79,110 shares of the power generation company at the end of 2018Q4, valued at $1.88 million, up from 45,213 at the end of the previous reported quarter. Kwmg Llc who had been investing in Pg&E Corp for a number of months, seems to be bullish on the $11.66B market cap company. The stock decreased 0.70% or $0.16 during the last trading session, reaching $22.1. About 2.24M shares traded. PG&E Corporation (NYSE:PCG) has declined 56.25% since April 17, 2018 and is downtrending. It has underperformed by 60.62% the S&P500. Some Historical PCG News: 20/03/2018 – Cal EMA Spills: SPILL Report – PG&E – 03/20/2018 06:52 PM; 27/04/2018 – Cal EMA Spills: SPILL Report – Pacific Gas & Electric – 04/27/2018 09:17 AM; 16/04/2018 – CORRECTED (OFFICIAL)-PG&E CA Diablo Canyon 1 reactor remains at 50 pct power (April 13); 24/04/2018 – PG&E, EDISON WOULD STILL BE SUBJECT TO CIVIL ACTION FROM FIRES; 03/05/2018 – PG&E CEO SAYS NO TIMING UPDATES FROM CALIFORNIA FIRE REPORTS; 03/05/2018 – PG&E CEO SEES MANY DIFFERENT CALIFORNIA FIRE BILLS EMERGING; 25/05/2018 – PG&E Believes Overall Programs Met State’s Standard; 05/04/2018 – Cal EMA Spills: SPILL Report – PG&E – 04/05/2018 08:05 AM; 03/05/2018 – PG&E INTENDS TO APPEAL BUTTE FIRE LEGAL DECISION; 03/05/2018 – PG&E 1Q Adj EPS 91c

Artal Group Sa increased its stake in Dicerna Pharmaceuticals Inc (DRNA) by 23.53% based on its latest 2018Q4 regulatory filing with the SEC. Artal Group Sa bought 100,000 shares as the company’s stock declined 14.00% while stock markets rallied. The institutional investor held 525,000 shares of the health care company at the end of 2018Q4, valued at $5.61 million, up from 425,000 at the end of the previous reported quarter. Artal Group Sa who had been investing in Dicerna Pharmaceuticals Inc for a number of months, seems to be bullish on the $948.88 million market cap company. The stock decreased 4.47% or $0.65 during the last trading session, reaching $13.9. About 198,794 shares traded. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) has 0.00% since April 17, 2018 and is . It has underperformed by 4.37% the S&P500. Some Historical DRNA News: 20/04/2018 – ADVISORY-Alert on Dicerna, Alnylam litigation settlement wrongly coded to American Lorain; 20/04/2018 – Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade Secret Misappropriation and Other Pending Litigation; 14/05/2018 – Dicerna Pharmaceuticals Believes It Has Sufficient Cash Through 2019, Assuming No New Fundin; 20/04/2018 – DICERNA PHARMACEUTICALS – SETTLEMENT EXCLUDES ANY AMOUNTS RECEIVED BY DICERNA FROM ITS EXISTING COLLABORATION WITH BOEHRINGER-INGELHEIM; 17/05/2018 – Dicerna Pharmaceuticals, Inc; 17/04/2018 – STAT Plus: Trade secrets battle between Alnylam, Dicerna is just one of many; 23/03/2018 – Report: Exploring Fundamental Drivers Behind Goldfield, Dicerna Pharmaceuticals, Deciphera Pharmaceuticals, WesBanco, Carolina; 20/04/2018 – ALNYLAM REACHES SETTLEMENT PACT WITH DICERNA PHARMACEUTICALS; 08/03/2018 – DICERNA PHARMACEUTICALS INC – QTRLY SHR LOSS $0.90; 30/05/2018 – DICERNA PHARMACEUTICALS INC – EXPECTS TO HAVE CLINICAL PROOF-OF-CONCEPT DATA FROM PHYOX TRIAL IN SECOND HALF OF 2018

Since October 30, 2018, it had 0 insider buys, and 2 selling transactions for $12.17 million activity.

More notable recent Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) news were published by: Nasdaq.com which released: “4 Drug/Biotech Stocks Making a Mark in RNAi Therapeutics – Nasdaq” on April 11, 2019, also Streetinsider.com with their article: “Dicerna Pharma (DRNA) Presents Updated Data from Ongoing PHYOX1 Phase 1 Clinical trial Evaluating DCR-PHXC – StreetInsider.com” published on March 29, 2019, Benzinga.com published: “36 Stocks Moving In Tuesday’s Pre-Market Session – Benzinga” on March 19, 2019. More interesting news about Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) were released by: Seekingalpha.com and their article: “Our Take On Dicerna Pharmaceuticals – Seeking Alpha” published on August 21, 2018 as well as Bizjournals.com‘s news article titled: “Bain Capital raising another life sciences fund after $720M debut – Boston Business Journal” with publication date: April 16, 2019.

Investors sentiment increased to 3.24 in 2018 Q4. Its up 0.99, from 2.25 in 2018Q3. It increased, as 10 investors sold DRNA shares while 11 reduced holdings. 26 funds opened positions while 42 raised stakes. 95.22 million shares or 115.10% more from 44.27 million shares in 2018Q3 were reported. 600 are owned by Daiwa Securities Grp Inc. 218,093 are owned by Bancorporation Of Ny Mellon. Northern Trust holds 0% or 647,143 shares in its portfolio. Federated Investors Pa owns 331,553 shares or 0.01% of their US portfolio. Metropolitan Life Ins New York has 0% invested in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) for 18,469 shares. Legal & General Public Ltd Co reported 9,186 shares. Rhumbline Advisers reported 67,192 shares stake. Dafna Cap Management Llc has 118,500 shares for 0.63% of their portfolio. California Employees Retirement System has invested 0% in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA). Quantitative Systematic Strategies Llc stated it has 30,828 shares or 0.07% of all its holdings. Emerald Mutual Fund Advisers Trust holds 909,220 shares. Ecor1 Llc reported 3.55% in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA). Macquarie has invested 0% in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA). State Of Wisconsin Invest Board holds 0% of its portfolio in Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) for 47,000 shares. Dorsey Wright holds 0% or 1,170 shares.

Artal Group Sa, which manages about $2.70B US Long portfolio, decreased its stake in Morgan Stanley (Call) (NYSE:MS) by 500,000 shares to 1.50M shares, valued at $59.48M in 2018Q4, according to the filing. It also reduced its holding in Bristol Myers Squibb Co (Call) (NYSE:BMY) by 200,000 shares in the quarter, leaving it with 550,000 shares, and cut its stake in Bluebird Bio Inc (Call) (NASDAQ:BLUE).

More notable recent PG&E Corporation (NYSE:PCG) news were published by: Seekingalpha.com which released: “ValueAct’s Ubben slams PG&E board selection process – Seeking Alpha” on March 20, 2019, also Fool.com with their article: “Why PG&E, Pioneer Natural Resources, and Adient Jumped Today – The Motley Fool” published on April 12, 2019, Seekingalpha.com published: “PG&E gets $5.5B in funds to keep operating during bankruptcy – Seeking Alpha” on March 27, 2019. More interesting news about PG&E Corporation (NYSE:PCG) were released by: Seekingalpha.com and their article: “California utility rates could soar if PG&E-linked wildfires continue, report says – Seeking Alpha” published on April 12, 2019 as well as Seekingalpha.com‘s news article titled: “PG&E’s proposed bankruptcy bonus should be denied, U.S. Trustee says – Seeking Alpha” with publication date: March 26, 2019.

Kwmg Llc, which manages about $365.55M US Long portfolio, decreased its stake in Scana Corp New (NYSE:SCG) by 7,709 shares to 49,062 shares, valued at $2.34M in 2018Q4, according to the filing. It also reduced its holding in Ishares Tr (SHV) by 3,343 shares in the quarter, leaving it with 33,811 shares, and cut its stake in Vanguard Bd Index Fd Inc (BSV).

Investors sentiment decreased to 0.67 in 2018 Q4. Its down 0.34, from 1.01 in 2018Q3. It turned negative, as 121 investors sold PCG shares while 146 reduced holdings. 63 funds opened positions while 117 raised stakes. 421.38 million shares or 6.35% more from 396.22 million shares in 2018Q3 were reported. Ironsides Asset Advsrs Limited Liability Com invested in 0.15% or 17,180 shares. Zimmer Prns Lp owns 1.50M shares. Newtyn Mngmt Limited, a New York-based fund reported 2.92 million shares. Landscape Mgmt Limited Liability Co has 59,787 shares. Amer Grp Inc Inc accumulated 185,055 shares. Nokota Mngmt LP owns 397,107 shares for 0.3% of their portfolio. Td Asset Mngmt invested in 0.01% or 163,396 shares. 1.75 million were reported by Brookfield Asset Mgmt. Hsbc Holdings Public Ltd Co reported 0.02% stake. Winslow Evans Crocker owns 218 shares or 0% of their US portfolio. 70 were accumulated by Corp. Centerbridge Partners LP owns 6.9% invested in PG&E Corporation (NYSE:PCG) for 2.86M shares. Ny State Teachers Retirement System holds 799,257 shares or 0.05% of its portfolio. Hbk Investments Lp holds 0.03% of its portfolio in PG&E Corporation (NYSE:PCG) for 81,735 shares. Moreover, Umb Fincl Bank N A Mo has 0.01% invested in PG&E Corporation (NYSE:PCG) for 20,592 shares.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Institutional Positions Chart